FDA Approved: ARGATROBAN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for Argatroban from Hikma Pharmaceuticals USA Inc., granting additional authorization under a supplemental application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Heparin-induced Thrombocytopenia

Drugs mentioned

• Argatroban (argatroban)

Snippet

SUPPL AP for ARGATROBAN (ARGATROBAN)